Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

ENTAENTA
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ENANTA PHARMACEUTICALS INC

JPMORGAN CHASE & CO holds 96,764 shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $1.4M as of 2026-Q2. The position was decreased (-6.1% shares). ENTA represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$1.4M

Current Shares

96,764

Total Value Change

+$466,144

Total Shares Change

-66,349

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
96,764
-6.1%
$1.4M0.0%$14.58
0
2026-Q1
Decreased
103,059
-8.8%
$1.3M0.0%$14.72
0
2025-Q4
Decreased
112,964
-54.4%
$1.8M0.0%$15.90
0
2025-Q3
Increased
247,634
+89.9%
$3M0.0%$15.16
41
2025-Q2
Decreased
130,433
-2.8%
$986,0740.0%$7.50
0
2025-Q1
Decreased
134,202
-17.7%
$740,7950.0%$5.71
0
2024-Q4
New
163,113
-
$937,9010.0%$5.85
35

Other major holders of ENTA: BNP PARIBAS FINANCIAL MARKETS, FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used